Clinical Trial Update: Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 study assessing the efficacy and safety of teneligliptin in Chinese patients with type 2 diabetes mellitus has completed, with results posted on 2022-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Teneligliptin (Teneligliptin)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2022-01-28